Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Usana Health Sciences (USNA) Other Operating Expenses (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Other Operating Expenses for 15 consecutive years, with $77.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Other Operating Expenses fell 7.59% to $77.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $348.2 million, a 4.88% decrease, with the full-year FY2024 number at $363.7 million, down 7.75% from a year prior.
  • Other Operating Expenses was $77.7 million for Q3 2025 at Usana Health Sciences, down from $87.0 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $161.2 million in Q1 2022 to a low of $77.7 million in Q3 2025.
  • A 5-year average of $102.5 million and a median of $95.9 million in 2023 define the central range for Other Operating Expenses.
  • Peak YoY movement for Other Operating Expenses: increased 15.88% in 2021, then plummeted 39.28% in 2022.
  • Usana Health Sciences' Other Operating Expenses stood at $134.5 million in 2021, then dropped by 27.22% to $97.9 million in 2022, then fell by 2.04% to $95.9 million in 2023, then decreased by 2.48% to $93.5 million in 2024, then fell by 16.92% to $77.7 million in 2025.
  • Per Business Quant, the three most recent readings for USNA's Other Operating Expenses are $77.7 million (Q3 2025), $87.0 million (Q2 2025), and $90.0 million (Q1 2025).